Abu Dhabi, 14 May 2025: The Abu Dhabi Public Health Centre (ADPHC) has signed a two-year Memorandum of Understanding (MoU) with Gilead Sciences Ireland to enhance disease prevention, early detection, and public awareness in key health areas in Abu Dhabi Emirate.

The MoU establishes a framework for collaboration between ADPHC and Gilead Sciences across two core pillars: disease awareness and education campaigns and screening and early detection and diagnosis. The partnership will focus on blood-borne viruses, including hepatitis B (HBV), hepatitis C (HCV), and HIV.